Víctor D. Cuevas

Víctor D. Cuevas

Auto-generated profile, based on publicly available information

Víctor D. Cuevas

Departamento de Biología Celular, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Cientificas, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
VCVíctor D. Cuevas
Víctor D. Cuevas
LALaura Anta
Laura Anta
RSRafael Samaniego
Rafael Samaniego
EOEmmanuel Orta-Zavalza
Emmanuel Orta-Zavalza
JRJuan Vladimir de la Rosa
Juan Vladimir de la Rosa
ACAngel L. Corbí
Angel L. Corbí
Macrophage phenotypic and functional heterogeneity derives from tissue-specific transcriptional signatures shaped by the local microenvironment. Most studies addressing the molecular basis for macrophage heterogeneity have focused on murine cells, whereas the factors controlling the functional specialization of human macrophages are less known. M-CSF drives the generation of human monocyte-derived macrophages with a potent anti-inflammatory activity upon stimulation. We now report that knockdown of MAFB impairs the acquisition of the anti-inflammatory profile of human macrophages, identify the MAFB-dependent gene signature in human macrophages and illustrate the coexpression of MAFB and MAFB-target genes in CD163+ tissue-resident and tumor-associated macrophages. The contribution of MAFB to the homeostatic/anti-inflammatory macrophage profile is further supported by the skewed polarization of monocyte-derived macrophages from multicentric carpotarsal osteolysis (Online Mendelian Inheritance in Man #166300), a pathology caused by mutations in the MAFB gene. Our results demonstrate that MAFB critically determines the acquisition of the anti-inflammatory transcriptional and functional profiles of human macrophages.

7 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ÁDÁngeles Domínguez-Soto
Ángeles Domínguez-Soto
AUAlicia Usategui
Alicia Usategui
MCMateo de Las Casas-Engel
Mateo de Las Casas-Engel
MSMiriam Simón-Fuentes
Miriam Simón-Fuentes
CNConcha Nieto
Concha Nieto
ÁCÁngel L. Corbí
Ángel L. Corbí
Peripheral serotonin (5-hydroxytryptamine, 5-HT) regulates cell growth and differentiation in numerous cell types through engagement of seven types of cell surface receptors (HTR1–7). Deregulated 5-HT/HTR levels contribute to pathology in chronic inflammatory diseases, with macrophages being relevant targets for the physio-pathological effects of 5-HT. In fact, 5-HT skews human macrophage polarization through engagement of 5-HT2BR and 5-HT7R receptors. We now report that 5-HT primes macrophages for reduced pro-inflammatory cytokine production and IFN type I-mediated signaling, and promotes an anti-inflammatory and pro-fibrotic gene signature in human macrophages. The acquisition of the 5-HT-dependent gene profile primarily depends on the 5-HT7R receptor and 5-HT7R-initiated PKA-dependent signaling. In line with the transcriptional results, 5-HT upregulates TGFβ1 production by human macrophages in an HTR7- and PKA-dependent manner, whereas the absence of Htr7 in vivo results in diminished macrophage infiltration and collagen deposition in a mouse model of skin fibrosis. Our results indicate that the anti-inflammatory and pro-fibrotic activity of 5-HT is primarily mediated through the 5-HT7R-PKA axis, and that 5-HT7R contributes to pathology in fibrotic diseases.

1 December 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MRMarta Riera-Borrull
Marta Riera-Borrull
VCVíctor D. Cuevas
Víctor D. Cuevas
BABárbara Alonso
Bárbara Alonso
MVMiguel A Vega
Miguel A Vega
JJJorge Joven
Jorge Joven
ACAngel L. Corbí
Angel L. Corbí
Obesity is associated with low-grade inflammation and elevated levels of circulating saturated fatty acids, which trigger inflammatory responses by engaging pattern recognition receptors in macrophages. Because tissue homeostasis is maintained through an adequate balance of pro- and anti-inflammatory macrophages, we assessed the transcriptional and functional profile of M-CSF–dependent monocyte-derived human macrophages exposed to concentrations of saturated fatty acids found in obese individuals. We report that palmitate (C16:0, 200 μM) significantly modulates the macrophage gene signature, lowers the expression of transcription factors that positively regulate IL-10 expression (MAFB, AhR), and promotes a proinflammatory state whose acquisition requires JNK activation. Unlike LPS, palmitate exposure does not activate STAT1, and its transcriptional effects can be distinguished from those triggered by LPS, as both agents oppositely regulate the expression of CCL19 and TRIB3. Besides, palmitate conditions macrophages for exacerbated proinflammatory responses (lower IL-10 and CCL2, higher TNF-α, IL-6, and IL-1β) toward pathogenic stimuli, a process also mediated by JNK activation. All of these effects of palmitate are fatty acid specific because oleate (C18:1, 200 μM) does not modify the macrophage transcriptional and functional profiles. Therefore, pathologic palmitate concentrations promote the acquisition of a specific polarization state in human macrophages and condition macrophages for enhanced responses toward inflammatory stimuli, with both effects being dependent on JNK activation. Our results provide further insight into the macrophage contribution to obesity-associated inflammation.

1 July 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ÁDÁngeles Domínguez-Soto
Ángeles Domínguez-Soto
MSMiriam Simón-Fuentes
Miriam Simón-Fuentes
MCMateo de Las Casas-Engel
Mateo de Las Casas-Engel
VCVíctor D. Cuevas
Víctor D. Cuevas
MLMaría López-Bravo
María López-Bravo
ACAngel L. Corbí
Angel L. Corbí
IVIg is an approved therapy for immunodeficiency and for several autoimmune and inflammatory diseases. However, the molecular basis for the IVIg anti-inflammatory activity remains to be fully explained and cannot be extrapolated from studies on animal models of disease. We now report that IVIg impairs the generation of human monocyte–derived anti-inflammatory macrophages by inducing JNK activation and activin A production and limits proinflammatory macrophage differentiation by inhibiting GM-CSF–driven STAT5 activation. In vivo, IVIg provokes a rapid increase in peripheral blood activin A, CCL2, and IL-6 levels, an effect that can be recapitulated in vitro on human monocytes. On differentiating monocytes, IVIg promotes the acquisition of altered transcriptional and cytokine profiles, reduces TLR expression and signaling, and upregulates negative regulators of TLR-initiated intracellular signaling. In line with these effects, in vivo IVIg infusion induces a state tolerant toward subsequent stimuli that results in reduced inflammatory cytokine production after LPS challenge in human peripheral blood and significant protection from LPS-induced death in mice. Therefore, IVIg conditions human macrophages toward the acquisition of a state of cross-tolerance against inflammatory stimuli, an effect that correlates with the net anti-inflammatory action of IVIg in vivo.

1 December 2014 in Cytotherapy
Verified
Journal Article
Open access
NCNatividad Cuende
Natividad Cuende
CBC. Boniface
C. Boniface
CBChristopher A. Bravery
Christopher A. Bravery
MFMiguel Forte
Miguel Forte
RGRaquel Giordano
Raquel Giordano
EJEdward B Jude
Edward B Jude